Adlai Nortye (ANL) Operating Leases (2022 - 2025)
Adlai Nortye's (ANL) quarterly Operating Leases came in at $1.1 million in Q4 2025, up 165.18% year-on-year from $425000.0 in Q4 2024, and up 165.18% on a QoQ basis from $425000.0 in Q4 2024.
Adlai Nortye (ANL) Operating Leases (2022 - 2025) Analysis & Trends
Adlai Nortye (ANL) has 4 years of Operating Leases data on file, last reported at $1.1 million in Q4 2025.
- On a quarterly basis, Operating Leases rose 165.18% year-over-year to $1.1 million in Q4 2025; TTM through Dec 2025 was $1.1 million, a 165.18% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, up 165.18% from the prior year.
- Operating Leases for Q4 2025 stood at $1.1 million, up from $425000.0 in the prior quarter.
- Over the last five years, Operating Leases for ANL reached as high as $1.2 million in Q4 2022 and fell as low as $425000.0 in Q4 2024.
- Historically, Operating Leases has averaged $814250.0 across 4 years, with a median of $798000.0 in 2023.
- Across the five-year window, Operating Leases sank 62.06% in 2023 and surged 165.18% in 2025, its largest moves.
- Year by year, Operating Leases stood at $1.2 million in 2022, then sank by 62.06% to $469000.0 in 2023, then retreated by 9.38% to $425000.0 in 2024, then jumped by 165.18% to $1.1 million in 2025.
- Per Business Quant data, the three most recent Operating Leases figures were $1.1 million in Q4 2025, $425000.0 in Q4 2024, and $469000.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Adlai Nortye | 1.16 Bn | 1.15 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.13 Mn |
| Dec 31, 2024 | 425,000.00 |
| Dec 31, 2023 | 469,000.00 |
| Dec 31, 2022 | 1.24 Mn |